Aims and objectives: To measure renal nurses' perceptions on assessing medication adherence in patients undergoing dialysis.
| INTRODUCTION
Medication nonadherence often leads to poor patient outcomes in chronic diseases (Ingersoll & Cohen, 2008) . The negative impact of nonadherence is such that alleviating it would result in greater public health gains than developing newer, costly therapies (Ingersoll & Cohen, 2008; Sabaté, 2003) . The reasons for nonadherence depend on the disease and the complexity of the regimens prescribed (Osterberg & Blaschke, 2005) . Chronic kidney disease (CKD) patients in general, and patients receiving dialysis, in particular, are at high risk of medication nonadherence. This may be due to an increased burden of concomitant illness and dialysis-related problems, leading to an increased complexity of various treatment regimens (Ghimire, Peterson, Castelino, Jose, & Zaidi, 2016) . In general, 50% of the patients undergoing dialysis do not adhere to part of their treatment regimen, with nonadherence to medication ranging between 12.5%-98.6% (Ghimire, Castelino, Lioufas, Peterson, & Zaidi, 2015; Kammerer, Garry, Hartigan, Carter, & Erlich, 2007) . The worsening of the underlying illness in patients undergoing dialysis following medication nonadherence has been associated with increased mortality and repeated hospitalisations, placing a substantial financial burden on the healthcare system (Ghimire et al., 2015) .
| BACKGROUND
The current research on medication adherence primarily focuses on understanding and changing the medication-taking behaviour of patients, rather than on understanding and changing the healthcare system inadequacies that may affect adherence in patients (Clyne et al., 2016; Mangan, Powers, & Lengel, 2013) . Patients who had shorter consultations with their doctor or a healthcare professional that lacked a discussion on medication-related issues were found to be nonadherent to their prescribed treatment (Rifkin et al., 2010; Williams, Manias, & Walker, 2008) . Engaging patients in a meaningful conversation about their medication use may not be a straightforward solution to this problem. Healthcare professionals have reported time availability and work pressures as barriers to assessing a patient's ability to take medications and to investigating any impediments to medication adherence (Williams et al., 2008) . Despite extensive research on the incidence, measurement and improvement of medication adherence (Osterberg & Blaschke, 2005) , little is known about the actual practices of measuring adherence in clinical settings. The extent to which renal nurses are aware of adherence measurement practices, and how much time is devoted to measuring and promoting adherence in patients undergoing dialysis, is unknown. Renal nurses working with patients get to know them well as they see them frequently, usually three times a week for a period of 3-5 hr a day. Such level of engagement provides an exceptional opportunity for the dialysis nurses to educate and promote medication adherence in patients undergoing dialysis.
Nevertheless, an understanding of dialysis nurses' perceptions of adherence assessment practices, and the likely barriers to monitoring, and improving medication adherence are essential before nurses can take part in any quality initiative targeting nonadherence.
Therefore, this study was designed to understand renal nurses' perceptions on medication adherence assessment practices in patients undergoing dialysis.
| METHODS

| Study design
An online cross-sectional survey method was used. We followed the STROBE guidelines for the design and reporting of this research (Vandenbroucke et al., 2007) .
| Setting and participants
All dialysis nurses practising in Australian dialysis settings were eligible to participate. We recruited participants through the professional renal association, the Renal Society of Australasia (RSA), as recruiting them directly was not practicable due to the absence of guaranteed means of identifying renal nurses individually.
| Data collection
An online survey was conducted for a period of 3 months between March-May 2016. We coordinated with the professional association to send information that described the study's aims, and which gave a web address for the survey, to dialysis nurses through email alerts, social media posts and e-newsletters. Reminders were sent on a fortnightly basis. After the survey was completed, we randomly selected eight participants who had opted in to win gift vouchers valued at AUD $100. Although offering incentives to respond has been found to influence survey response (Eleanor & Cong, 2012) , the draw amount was insignificant for the nursing professionals, and our intention was mainly to thank participants for their contribution.
What does this paper contribute to the wider global clinical community?
• Little is known about the renal nurses' practices of assessing medication adherence during the routine care of patients undergoing dialysis.
• Renal nurses rely on routine laboratory results to detect medication nonadherence, with little to no attention being paid to patient engagement via self-reported measures.
• Lack of time, lack of support from hospital administration and patients' disinterest in communicating medicationrelated issues to renal nurses were perceived as barriers to assessing adherence. GHIMIRE ET AL.
| Survey instrument
During the thorough literature search, we could not identify any validated tools that particularly measured dialysis nurses' perceptions regarding adherence assessment practices. Hence, we adapted a previously developed survey instrument that measured renal pharmacists' perceptions and practices of assessing adherence in dialysis settings (Ghimire, Banks, Jose, Castelino, & Zaidi, 2018) . To briefly describe the instrument, it comprised seven sections that explored demographics, perceptions of the prevalence of, and contributors to nonadherence, the perceived effectiveness of methods used to detect nonadherence, barriers to adherence assessment and participants' confidence in assessing adherence. A 10-point Likert scale of agreement was used to measure perception (1 = strongly disagree, 10 = strongly agree). The last section comprised questions related to the current practices of assessing adherence in dialysis patients and used 4-point graded response where one meant "do not practice at all," and four meant "practice for every patient."
| Statistical analysis
Data were entered and analysed in SPSS version 23.0 (IBM Corp., Armonk, NY, USA). Demographic characteristics were ascertained through descriptive analysis. Kolmogorov-Smirnov and ShapiroWilks tests were performed to assess normality. Perception scores were summarised using the median and the interquartile range.
Mann-Whitney or Kruskal-Wallis tests were performed to detect the differences in median scores for nonnormally distributed data.
The Dunn-Bonferroni test was used to identify statistically significant differences between intergroup variables as a post hoc analysis (Dunn, 1964 ). Cronbach's alpha coefficient was used to measure the internal consistency reliability of the perception scales. A p value of <0.05 was considered statistically significant. 
| Ethics
| RESULTS
A total of 113 renal nurses completed the survey. The majority of the participants were female (92.0%, n = 104), with 11-20 years of experience in renal units (47.8%, n = 54). As participants were recruited indirectly through the RSA, which has over 1,800 members, including nurses, technicians, social workers, dietitians and other allied health professionals, we could not gauge the actual survey response rate for renal nurses alone. Nevertheless, this study was not aimed at generalisability, but for developing and piloting the survey instrument to inform larger nationwide studies in dialysis settings. The characteristics of the respondents are presented in Table 1 . 
| Internal consistency and reliability of scales
| Perceived prevalence and contributors of nonadherence
The majority of renal nurses believe dialysis patients in their unit often forget to take their medicines (median = 8), rarely ask questions about medicines (median = 7), are unable to answer medicinerelated questions (median = 7) and are often confused about their medicines (median = 7). The majority of the nurses thought that having limited understanding of their disease (median = 7), being prescribed with complex medication regimens (median = 7), lacking family or social support (median = 7), having low educational backgrounds (median = 7) and low income (median = 7) contributed to medication nonadherence in dialysis patients. The majority of the participants disagreed that being older (median = 4) or male (median = 5) contributed to nonadherence behaviour, however (Table 2 ).
| Perceived effectiveness and barriers to assessing adherence
The majority of renal nurses agreed that having dedicated professionals who take medication histories (median = 8) or having pharmacists who conduct medication reviews and reconciliations (median = 9) can be effective in assessing adherence. High median ratings were also observed for the effectiveness of assessing adherence through objective methods, such as blood results or physical assessment (median = 8), and through subjective methods, such as conducting medication history interviews (median = 8).
Renal nurses disagreed that they lacked the knowledge and skills to assess adherence (median = 2), but over one-third perceived that they lacked the time needed to undertake adherence-promoting activities (median = 4). Furthermore, over a third of the participants reported that they lacked administrative support from hospital in conducting adherence-promoting activities (median = 5). Nearly a quarter of the nurses also perceived that patients are not interested in discussing medication-related issues with them (median = 3) (Table 3 ).
| Participants' confidence in assessing adherence
Dialysis nurses' median confidence ratings were higher in terms of ability to suggest strategies to improve adherence (median = 8), followed by ability to assess patients' knowledge and beliefs about medicines (median = 8), conduct a medication history interview (median = 8) and provide medication counselling (median = 8) (Table 3) experience were less confident in assessing adherence than participants with 11-20 years (median: 7 vs. 8, p < 0.05) and with ≥21 years (median: 7 vs. 8, p < 0.05) of experience (Table 4 ). 
| Current practices of assessing adherence
| Qualitative comments
The qualitative comments reinforced the survey findings regarding contributors of nonadherence, such as lack of knowledge about medicines, comorbid illnesses, tablet burden, culture and communication barriers, lack of support, forgetfulness and relative affordability of medicines. Nurses also highlighted the need for a sustainable strategy to empower self-management in patients taking long-term medications. There was a recurring theme in the desire for a designated renal pharmacist in dialysis settings to manage medication-related issues.
Furthermore, nurses reported that patients trusted their doctors with medical decisions and preferred communicating with them rather than with the nurses. Due to long waiting times for consultations, however, their medication-related queries remain unanswered. This subsequently nurtured nonadherence behaviour in patients undergoing dialysis. The comments are given in Supporting Information Appendix S2.
| DISCUSSION
We reported renal nurses' perceptions on assessing medication adherence in patients undergoing dialysis. The internal consistency Notes. Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; n represents number of participants responding to each item in a questionnaire. IQR, interquartile range.
and reliability of the overall scale were good. The findings from this study suggest that current adherence assessment practices are suboptimal, and the methods used to screen patients' medication-taking behaviour are used less in dialysis settings. Renal nurses seemed to be confident in conducting adherence assessment activities, and their level of confidence increased with increased work experience.
Lack of time, lack of support from hospitals and patients' disinterest in discussing medication-related issues with the nurses were perceived as barriers to assessing adherence. The majority of the nurses acknowledged that having a dedicated pharmacist would be effective in promoting adherence activities, but these services are rarely available in dialysis centres.
| Nurses' perceptions on medication nonadherence in dialysis patients
Health professionals are often overly optimistic about adherence behaviour in their patients (Patel & Davis, 2006) ; however, renal nurses in this study acknowledged the high prevalence of nonadherence behaviour in patients undergoing dialysis. Although adherence to any treatment regimen is a subject of maximum interest, one must not forget the reason why many patients do not adhere to their medications as prescribed. Often this might be an avoidance coping strategy, whereas at other times this might be due to ignorance. As each individual presents with a unique set of circumstances, efforts must be made to understand the reasons behind nonadherence. Renal nurses' perceptions, in this study, corroborated with earlier findings that patient-related factors, such as lack of knowledge about medicines, lack of social support, comorbid conditions, forgetfulness, medication burden, affordability and culture and communication barriers, could influence adherence (Brar, Babakhani, Salifu, & Jindal, 2014; Griva et al., 2013; Lindberg & Lindberg, 2008; Manley et al., 2004) .
| Current adherence assessment practices
We observed that current adherence assessment practices are limited and that the methods used to monitor nonadherence behaviour, such as medication history taking, and medication reviews and reconciliation by pharmacists, were only occasionally conducted, whereas objective blood monitoring was a routine practice in most settings. A recent survey on renal pharmacists' perceptions corroborated the study's findings on current adherence assessment practices in dialysis settings (Ghimire et al., 2018) . Objective blood monitoring in patients undergoing dialysis is mainly conducted to ensure that the dialysis prescription, that is, the time and type of the dialysis treatments, is optimal. Although we can also draw inferences from blood results to see whether patients are adherent to their Asking patients to bring medications and count (n = 107) 42.1 57.9 7 (4-8)
Having a dedicated professional to take medication history (n = 108) 11.1 88.9 8 (7-9)
Conducting medication reviews and reconciliation by Pharmacist (n = 108) 13.0 87.0 9 (8-10)
Perceived barriers
Lack of knowledge and skills to assess nonadherence (n = 108) 88. Ability to clarify patient's medication queries (n = 108) 15.7 84.3 7 (6-9)
Ability to suggest strategies to improve adherence (n = 108) 7.4 92.6 8 (7-9)
Ability to assess patient's knowledge and beliefs about medications (n = 108) 13.0 87.0 8 (7-9)
Notes. Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; n represents number of participants responding to each item in a questionnaire. BP, blood pressure; IQR, interquartile range; SPL, serum phosphate levels.
medications, particularly, phosphate binders, the reliability of these results can be questioned as they can be affected by various dietary and clinical factors. A preferable approach would be to combine objective measures with subjective ones, such as patient interviews or validated adherence assessment questionnaires (Brar et al., 2014) .
This may also help to overcome the subjective bias of patient selfreports (Hsu et al., 2015; Wileman et al., 2014).
| Barriers to adherence assessment practices
The ability to conduct adherence assessments and promotion activities in dialysis centres may largely depend upon overcoming the barriers recognised in this study, such as time and resource limitations, a lack of hospital support and most importantly unwillingness from both patients and health professionals to actively participating in Notes. Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; in cases where two or more groups have equal medians, the distribution of these groups is represented by mean rank. For some patients (with higher risk of adverse effects)
Not applicable (do not practice at all) F I G U R E 1 Nurses' reports on current practices of assessing medication adherence in dialysis patients in Australia discussions to resolve medication-related issues. The delivery of adherence support activities by renal healthcare professionals will also depend upon the knowledge and skills they acquire through tailored education and training and routine practices (Bajorek et al., 2015; Dayer, Dunn, Pace, & Flowers, 2016) .
Dialysis nurses in this study largely disagreed that they lack the knowledge and skills needed to conduct adherence assessment activities and were instead highly confident about this. The fact that dialysis nurses are involved in managing and assessing the health needs of the patients on a daily basis, and in educating patients about their diseases, prognoses and treatments may have contributed to higher confidence scoring. Expectedly, the majority of the renal nurses also endorsed the inclusion of dedicated professionals, especially renal pharmacists, in undertaking adherence assessment activities in patients undergoing dialysis. Positive perceptions towards pharmacists' roles may be due to past experiences of interprofessional collaborations, and awareness of the competency and contribution of pharmacists in delivering pharmaceutical care services (Chevalier & Neville, 2011; Salgado, Moles, Benrimoj, & Fernandez-Llimos, 2013; Sulick & Pathak, 1996) . Interventions by the pharmacists have resulted in reduced hospitalisation, improved patient satisfaction and reduced overall treatment expenses in patients undergoing dialysis (Salgado, Moles, Benrimoj, & Fernandez-Llimos, 2012) .
| Integrating adherence assessment practices within nursing roles
The availability of renal pharmacy services in Australian outpatient dialysis centres is extremely limited (Salgado et al., 2012) . Centres receiving pharmacy services on "as necessary" basis might call upon pharmacists for medication reviews only on occasions when a patient's condition is severe and demands inspection of their medication regimen. Although the presence of a dedicated professional or renal specialised pharmacist who can exclusively focus on medication management and adherence-promoting activities would be an ideal solution, it is unlikely that this will be integrated into every dialysis centre anytime soon due to time and resource availability (Mangan et al., 2013) , finances and organisational factors (Roberts, Benrimoj, Chen, Williams, & Aslani, 2006; Salgado et al., 2012) . Alternative measures include empowering the existing renal nursing services within the dialysis centres as they are the professionals who closely engage with the patients and are ideally placed to deliver medicines, monitor patient progress and educate patients in medication selfmanagement to promote adherence (Emsley et al., 2015; Kammerer et al., 2007) . Nevertheless, the existing workload of the dialysis nurses and the barriers to successful incorporation of auxiliary roles, such as adherence assessment and promotion activities, need to be carefully considered in dialysis settings.
| Implications for nursing practice
A recent systematic review of trials that assessed the effects of nursing interventions on improving medication adherence among discharged, home-dwelling and older adults suggested that nurse-led and nurse-collaborative interventions moderately improved medication adherence in discharged older adults (Verloo, Chiolero, Kiszio, Kampel, & Santschi, 2017) . Likewise, a nurse-delivered, self-care intervention programme for chronic heart failure patients has been found to be effective in improving patients' adherence (Granger et al., 2015) . Designing nurse-led tailored interventions suitable for use during dialysis sessions that educate patients on problem-solving, guide behavioural change and teach them to take action in response to wavering signs and symptoms can be an effective self-management strategy for improving medication adherence in patients undergoing dialysis (Lindberg & Lindberg, 2008) .
Renal nurses, in this study, also emphasised that sustainable strategies for empowering self-management in patients taking longterm medications, and having trusted relationships with healthcare providers, can have a significant influence on patients' adherence.
Patients become truthful about taking medication only if they are comfortable to admit their difficulties with no risk of criticism, and when there is a true partnership with their healthcare providers (Martin, Williams, Haskard, & Dimatteo, 2005) . Patients with CKD who express dissatisfaction due to an absence of guidance and a lack of discussion about medication-related issues during consultations are found to be less motivated to follow treatment recommendations, to hide their concerns, and to acquire nonadherence behaviours (Rifkin et al., 2010) . Therefore, it is imperative that renal healthcare professionals routinely instigate discussions on medication-related issues with the patients undergoing dialysis.
| Study limitations
Participants were not directly recruited; instead, email alerts, e-newsletters and social media posts from the professional organisation were relied upon. As such, an absolute denominator for the survey response rate could not be ascertained. This may have led to the inclusion of self-selected participants who were more interested in sharing their perceptions. Nevertheless, an even amount of participation was observed from rural and metropolitan areas, as well as from public and private dialysis centres. The study findings may not be generalisable to dialysis settings across Australia, for example, New
South Wales has the highest number of dialysis centres, but there was poor representation from the renal nurses. Nevertheless, the scope of this study was mainly to generate baseline observations to inform larger nationwide surveys.
| CONCLUSION S
Clinicians spend a great deal of time prescribing the best possible medications for their patients, yet little attention is paid to measuring adherence and ensuring that patients are adhering to their 
RELEVANCE TO CLINICAL PRACTICE
The findings from this study emphasise the need for proper assessment of dialysis patient's medication-taking behaviour during routine dialysis to ensure the benefits of prescribed therapies. Recognition of medication nonadherence in patients will allow healthcare providers and patients to make a collaborative effort in developing patient-specific tailored solutions to address the problem of medication nonadherence.
